Log in
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Dynamic quotes 

MarketScreener Homepage  >  Equities  >  Nasdaq  >  Autodesk, Inc.    ADSK


SummaryMost relevantAll NewsPress ReleasesOfficial PublicationsSector newsMarketScreener StrategiesAnalyst Recommendations

Take Five: Coronavirus vaccine race is on

05/26/2020 | 04:50am EST
FILE PHOTO:  Passersby wearing protective face masks are reflected on a screen displaying stock prices outside a brokerage in Tokyo


U.S. President Donald Trump has put his faith in anti-malarial drug hydroxychloroquine to ward off COVID-19, but governments and investors are focusing on a vaccine. Without one, it's unlikely economic activity can resume fully.

So the race is on, and the rewards are rich: AstraZeneca has vaulted into the position of the most valuable British company after receiving a U.S. pledge for up to $1.2 billion for its experimental vaccine.

Novavax Inc said on Monday it has started the Phase 1 clinical trial of a novel coronavirus vaccine candidate and has enrolled the trial's first participants, with preliminary results slated for July.

Pharma/biotech shares have outperformed broader equities since Feb 19. Investors twitchy for vaccine news sent the share price of biotech company Moderna 20% higher when it said its vaccine trials showed promise. Rivals Novavax and Inovio also rose when they secured vaccine development funding.

The United States has vaccine development deals with Johnson & Johnson and Sanofi, too. But many others, big and small, are in the race: Imperial College, Gilead Sciences, Roche, China's CanSino Biologics and India's Glenmark to name just a few.

(GRAPHIC: Healthcare outperforms -



European clashes over how to handle the economic impact of the COVID-19 crisis raised fears for the bloc's future, but a Franco-German proposal aimed at helping the worst-hit states represents a pivotal moment.

The "frugal four" - EU member states Austria, Sweden, Denmark and the Netherlands - stated their opposition on Saturday to the French-German plan, calling for a loans-based approach instead.

However, markets want to the see the details. All eyes will be on the European Commission, which on Wednesday presents its pandemic recovery plan.

The task is to ensure weaker states such as Italy can access funding without adding to their debt burden. But EU states remain divided over whether recovery funds should be funnelled through loans or transfers. If those opposed to big spending manage to water down the plan, the euro and southern European bonds will take a knock.

The change in Germany's previously hardline stance was momentous. Now it's the turn of others such as Austria and the Netherlands to decide if and how they might be ready to cross the Rubicon.

(GRAPHIC: Euro in the coronavirus crisis -



Beijing's control has long been a sore point for some Hong Kongers. Its latest proposal for a tougher national security regime for the city will almost certainly lead to further violent confrontations on the streets and open a new venue for Sino-U.S. tension.

Only this time it may be worse, which is why the Hang Seng index was hit harder on Friday than even the worst days in the March selldown. China has replaced the leadership in its Hong Kong Liaison office and, foreign envoys reckon, quietly doubled the number of staff there.

The United States has already warned of a tough response. Investors will look there, and to the situation on the ground for cues. As for markets, Hong Kong's property index posted its worst drop in 11.5 years on Friday. European luxury shares and banks such as HSBC also took a hammering on Friday, meaning ripples could spread. -China set to impose new Hong Kong security law, Trump warns of strong U.S. reaction

(GRAPHIC: Hong Kong protests take toll on domestic demand -



Coronavirus is a double-edged sword for cloud-computing firms. It has supercharged demand for datacenter services to support video-streaming and other remote services, but is also forcing corporates to slash budgets amid a deep recession.

Cloud computing players take the spotlight on Wall Street in coming days as they report quarterly results and guide investors on the outlook. Autodesk and Workday report on Wednesday. Salesforce.com - viewed as the gold standard - follows on Thursday, along with systems software seller VMWare.

The First Trust Cloud Computing index ETF has gained over 10% in 2020, although some big-name cloud-computing stocks have yet to fully recover from their March lows.

(GRAPHIC: Cloud stocks float higher -



Armed with less fiscal firepower and weaker healthcare systems than richer peers, emerging economies have been less able to counter coronavirus-induced drops in consumption, foreign investment and exports, or alleviate the effects of job losses.

That strain shows up in economic data, not least the 6.8% Q1 contraction in China's economy, the biggest in decades. Soon four other emerging market heavyweights - Turkey, Mexico, Brazil and India - will tell us how their growth fared in the January-April quarter.

Expect gloomy readings. India, not long ago the fastest-growing big economy, is expected to have expanded 2% in Q1; Turkey's economy is seen contracting this year for the first time in over a decade. For Brazil and Mexico Goldman Sachs predicts full-year contractions of 7.4% and 8.5% respectively.

(GRAPHIC: Reuters Poll: Coronavirus impact on the Indian economy -


(Reporting by Sujata Rao, Dhara Ranasinghe and Tom Arnold in London, Tom Westbrook in Singapore and Lewis Krauskopf in New York, additional reporting by Karin Strohecker in London; Editing by Hugh Lawson, William Maclean)

© Reuters 2020
Stocks mentioned in the article
ChangeLast1st jan.
ACCESS CO., LTD. -0.26% 755 End-of-day quote.2.72%
ASTRAZENECA PLC 0.44% 7592 Delayed Quote.3.66%
AUTODESK, INC. -0.84% 308.51 Delayed Quote.1.89%
CANSINO BIOLOGICS INC. 1.83% 234.2 End-of-day quote.32.69%
CHANGE INC. -0.15% 3380 End-of-day quote.-4.11%
EURO / BRAZILIAN REAL (EUR/BRL) 1.25% 6.3926 Delayed Quote.-0.49%
GILEAD SCIENCES, INC. 1.49% 63.33 Delayed Quote.8.70%
HANG SENG 0.39% 28620.49 Real-time Quote.5.10%
HSBC HOLDINGS PLC -1.21% 403.25 Delayed Quote.6.44%
INMED PHARMACEUTICALS INC. -2.36% 5.38 Delayed Quote.29.64%
MOMENTOUS HOLDINGS CORP. 0.00% 0.1 Delayed Quote.-9.09%
NOVAVAX, INC. -1.96% 127.43 Delayed Quote.14.28%
ONE STOP SYSTEMS, INC. -4.04% 4.75 Delayed Quote.18.75%
SANOFI 0.69% 81.53 Real-time Quote.3.60%
THE GOLDMAN SACHS GROUP, INC. -2.23% 301.01 Delayed Quote.14.14%
THE LEAD CO., INC. 1.69% 842 End-of-day quote.0.24%
US DOLLAR / TURKISH LIRA (USD/TRY) 0.00% 7.4733 Delayed Quote.0.28%
VMWARE, INC. -0.55% 134.81 Delayed Quote.-3.89%
WORKDAY INC. -2.10% 222.56 Delayed Quote.-7.12%
All news about AUTODESK, INC.
01/15AUTODESK : Employees Celebrate a Year of Giving Back
01/15AUTODESK : Credit Suisse Adjusts Autodesk's Price Target to $340 from $275, Keep..
01/14AUTODESK : Oppenheimer Adjusts Autodesk PT to $350 From $300, Maintains Outperfo..
01/12AUTODESK : Construction Cloud Increasingly Adopted by Leading Infrastructure Con..
01/07AUTODESK : Netfabb Joins Fusion 360 Family, Better Uniting Additive Manufacturin..
01/07AUTODESK : Veteran Autodesker Promoted to Lead Media & Entertainment Group
01/06AUTODESK : Barclays Adjusts Autodesk PT to $324 From $295, Maintains Overweight ..
01/05AUTODESK : KeyBanc Adjusts Autodesk's Price Target to $345 From $310, Maintains ..
2020AUTODESK : Applauds Customer Excellence in Artistry in Media & Entertainment Ind..
2020AUTODESK : Sponsors Independent Report Offering Customer & Employee Strategies f..
More news
Financials (USD)
Sales 2021 3 761 M - -
Net income 2021 424 M - -
Net cash 2021 255 M - -
P/E ratio 2021 161x
Yield 2021 -
Capitalization 67 838 M 67 838 M -
EV / Sales 2021 18,0x
EV / Sales 2022 15,4x
Nbr of Employees 10 100
Free-Float 99,4%
Duration : Period :
Autodesk, Inc. Technical Analysis Chart | MarketScreener
Full-screen chart
Technical analysis trends AUTODESK, INC.
Short TermMid-TermLong Term
Income Statement Evolution
Mean consensus OUTPERFORM
Number of Analysts 21
Average target price 303,35 $
Last Close Price 308,51 $
Spread / Highest target 19,9%
Spread / Average Target -1,67%
Spread / Lowest Target -35,8%
EPS Revisions
Managers and Directors
Andrew Anagnost President, Chief Executive Officer & Director
Stacy J. Smith Non-Executive Chairman
Steven M. Blum Senior Vice President-World Wide Field Operations
Scott Borduin Chief Technology Officer & Senior Vice President
Mary T. McDowell Independent Non-Executive Director
Sector and Competitors
1st jan.Capitalization (M$)
AUTODESK, INC.1.89%67 838
ADOBE INC.-8.41%219 750
TWILIO INC.14.82%58 691
WORKDAY INC.-7.12%53 597